Bd announces completion of embecta corp. spinoff

Franklin lakes, n.j. , april 1, 2022 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that it has completed its spinoff of embecta corp. (embecta) (nasdaq: embc), which holds bd's former diabetes care business and is now one of the largest pure-play diabetes management companies in the world.
BDX Ratings Summary
BDX Quant Ranking